Lam Research: This one-year call option was timed perfectly

portai
I'm LongbridgeAI, I can summarize articles.

After the market closed yesterday, I reviewed the options flow and noticed a set of operations on Lam Research that caught my attention—someone built a structure in two steps during the trading session: "using the money from selling Puts to buy calls expiring in a year." The result was that Micron's earnings report that night blew expectations, and the stock price surged 7% after hours. The timing was just too coincidental.

$Lam Research(LRCX.US) had just hit a new high a few days ago. On 6/23, the entire semiconductor sector followed the memory chain in a pullback, and it fell 9% in a single day, which was quite scary. On 6/24, it stabilized during the trading session, but after hours, Micron's Q3 earnings report far exceeded expectations—as a direct beneficiary of "selling shovels" in the semiconductor equipment sector, Lam Research surged to $400.97 after hours, just a step away from the high point a few days earlier.

Looking at the two intraday options flows separately:

The first one, at 09:42 AM ET, someone sold Puts expiring on 7/17 with a strike of K250, collecting about $730,000 in premium. $Lam Research(LRCX.US) was trading at 374, and K250 is an extremely out-of-the-money Put, 32% down—in other words, unless LRCX crashes 30% within a month, this Put sale is basically free money. This expresses "I'm convinced it won't fall significantly in the short term."

The second one, at 14:08 PM ET, $5.39 million was spent on the same stock to buy Calls expiring in June 2027 with a strike of K450—this is a 358-day LEAPS call, a solid one-year bullish heavy position.

Combined, these two trades form a classic financed bullish strategy: using the premium collected from selling extremely out-of-the-money Puts to subsidize the cost of buying long-dated Calls, with a net outlay of about $4.66 million. My understanding is that some institution is betting that Lam Research will continue to rise over the next year, pushing towards $450 or even higher, while having no concern about short-term pullbacks—the post-market surge driven by Micron's earnings that night served as an immediate validation of this bet.

If we scale this down to a retail-sized version: buying the K450 LEAPS Call, based on the day's premium cost per share, would be about $82.9/share, meaning Lam Research would need to rise to around $533 in a year to truly break even—this breakeven point is actually quite high, requiring a 42% increase from the current price of 374. The maximum loss is the premium paid for this Call; if the stock isn't above 450 in a year, it expires worthless, and you take the loss and move on, no need to overthink it.

I'm thinking, the breakeven point for buying this LEAPS Call alone is too far up, making the risk-reward ratio mediocre. If I were to play it myself, I'd be more likely to sell another Call at a higher strike to turn it into a Bull Call Spread, lowering the breakeven point at the cost of capping some of the upside potential—a trade-off between risk and reward.

We also need to be clear about the risks. The biggest enemy of this structure isn't direction, but time and IV (Implied Volatility). After surging 7% post-market, IV is pushed very high by the earnings sentiment. Chasing in now means buying when premiums are most expensive. If the stock gaps up on 6/25 and then pulls back, and IV crushes, the time value of the Call could decay faster than the stock price falls. So even if the direction is correct, the entry timing is crucial. Instead of chasing hard at the post-market +7% sentiment high, it's better to wait for some of the opening volatility on 6/25 to settle and for IV to come down a bit before looking again. If it breaks below the intraday low of $361 on 6/24, it means the earnings-driven momentum failed, and this bullish logic should be put on hold. Meanwhile, if the semiconductor capital expenditure cycle this round is even stronger than I think, and Lam's stock price simply doesn't pull back, that would be a missed opportunity.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.